About Grünenthal

Grünenthal is a science-based pharmaceutical company specialising in pain management and related diseases. With over 75 years of research experience and 4,300 employees across 28 countries, the company develops innovative, non-opioid therapies for patients living with acute and chronic pain. Their medicines reach over 100 countries worldwide. As a privately-owned company, Grünenthal combines long-term investment in research with strategic growth. Their integrated operations span discovery, clinical trials, manufacturing, and commercial distribution across Europe, Latin America, and the United States. This commitment to innovation supports their vision of a world free of pain.